SCHEMBL5843

SCHEMBL5843

CCOC[C@]1(O)CC[C@@]2(CCN(c3ccc(C4CC4)cc3)C2)CC1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ITGB3 P05106 7/20 0.37
ITGA2B P08514 7/20 0.37
CYP3A4 P08684 9/20 0.35
CYP2C9 P11712 4/20 0.35
CYP1A2 P05177 4/20 0.35
ALDH1A1 P00352 4/20 0.35
USP2 O75604 4/20 0.35
HSD17B10 Q99714 4/20 0.35
HIF1A Q16665 2/20 0.35
ALOX15 P16050 1/20 0.35
MAPK1 P28482 1/20 0.35
CYP2C19 P33261 5/20 0.34
TSHR P16473 2/20 0.34
MEN1 O00255 1/20 0.33
HPGD P15428 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CYP2D6 P10635 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5474 0.91 ITGB3 (0.36) ITGB3ITGA2BCYP3A4CYP2C9CYP1A2
SCHEMBL5381 0.88 CYP3A4 (0.39) ITGB3ITGA2BCYP3A4CYP2C9CYP1A2
SCHEMBL5924 0.84 ITGB3 (0.38) ITGB3ITGA2BCYP3A4CYP2C9CYP1A2
SCHEMBL5667 0.84 CYP3A4 (0.37) ITGB3ITGA2BCYP3A4CYP2C9CYP1A2
SCHEMBL5558 0.80 ESR2 (0.46) ITGB3ITGA2BCYP3A4CYP2C9CYP1A2
SCHEMBL5834 0.75 S1PR1 (0.37) ITGB3ITGA2BCYP3A4CYP2C9CYP1A2
SCHEMBL12702427 0.75 LIPE (0.54)
SCHEMBL1589509 0.75 LIPE (0.54)
SCHEMBL1589508 0.75 LIPE (0.54)
SCHEMBL5655 0.73 CYP3A4 (0.40) CYP3A4CYP2C9CYP1A2ALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488493-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. Hoffmann-La Roche AG (CH) 2012-08-22 EP disclosed
WO-2011045292-A1 SPIRO-CONDENSED CYCLOHEXANE DERIVATIVES AS HSL INHIBITORS USEFUL FOR THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2011-04-21 WO disclosed